Dual tracer tau PET imaging reveals different molecular targets for 11C-THK5351 and 11C-PBB3 in the Alzheimer brain-Reference-Cited by-同舟云学术

Dual tracer tau PET imaging reveals different molecular targets for 11C-THK5351 and 11C-PBB3 in the Alzheimer brain

Published:2018-05-12 Issue:9 Volume:45 Page:1605-1617
ISSN:1619-7070
Container-title:European Journal of Nuclear Medicine and Molecular Imaging
language:en
Short-container-title:Eur J Nucl Med Mol Imaging

Author:

Chiotis Konstantinos,Stenkrona Per,Almkvist Ove,Stepanov Vladimir,Ferreira Daniel,Arakawa Ryosuke,Takano Akihiro,Westman Eric,Varrone Andrea,Okamura Nobuyuki,Shimada Hitoshi,Higuchi Makoto,Halldin Christer,Nordberg Agneta

Funder

Vetenskapsrådet

Stiftelsen för Strategisk Forskning

Regional Agreement on Medical Training and Clinical Research (ALF) for Stockholm County Council

Stiftelsen för Gamla Tjänarinnor

Stiftelsen Sigurd and Elsa Goljes Minne

Axel Linders Stiftelse

Gun och Bertil Stohnes Stiftelse

KI Funds

Hjärnfonden

Alzheimerfonden

Demensförbundet

KTH-SLL grants

EU FW7 large-scale integrating project INMiND

Publisher

Springer Science and Business Media LLC

Subject

Radiology Nuclear Medicine and imaging,General Medicine,Radiology Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/article/10.1007/s00259-018-4012-5/fulltext.html

Reference53 articles.

1. Hyman BT, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Carrillo MC, et al. National Institute on Aging-Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease. Alzheimers Dement. 2012;8:1–13. https://doi.org/10.1016/j.jalz.2011.10.007 .

2. Saint-Aubert L, Lemoine L, Chiotis K, Leuzy A, Rodriguez-Vieitez E, Nordberg A. Tau PET imaging: present and future directions. Mol Neurodegener. 2017;12:19. https://doi.org/10.1186/s13024-017-0162-3 .

3. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82:239–59.

4. Delacourte A, David JP, Sergeant N, Buee L, Wattez A, Vermersch P, et al. The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer’s disease. Neurology. 1999;52:1158–65.

5. Ono M, Sahara N, Kumata K, Ji B, Ni R, Koga S, et al. Distinct binding of PET ligands PBB3 and AV-1451 to tau fibril strains in neurodegenerative tauopathies. Brain. 2017;140:764–80. https://doi.org/10.1093/brain/aww339 .

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Advances in the Diagnosis of Alzheimer's Disease: A Brief Overview of Tau PET Tracers in Nuclear Medicine;Current Radiopharmaceuticals;2024-07-19

2. Exploratory Tau PET/CT with [11C]PBB3 in Patients with Suspected Alzheimer’s Disease and Frontotemporal Lobar Degeneration: A Pilot Study on Correlation with PET Imaging and Cerebrospinal Fluid Biomarkers;Biomedicines;2024-07-01

3. Molecular Mechanisms in Drug Delivery;Microbiology-2.0 Update for a Sustainable Future;2024

4. [¹¹C]PBB3 binding in Aβ(–) or Aβ(+) corticobasal syndrome;Synapse;2023-04-30

5. The Sensitivity of Tau Tracers for the Discrimination of Alzheimer’s Disease Patients and Healthy Controls by PET;Biomolecules;2023-02-03